Seminars» Go to seminars main
Founder and Chief Scientific Officer
Soricimed Biopharma Inc.
Targeting the oncochannel TRPV6: deployment of TRPV6-binding peptides for treatment and diagnosis
Wednesday, October 07, 2015 - 4 to 5 p.m.
Theatre A, Sir Charles Tupper Medical Building (Halifax)
Room 102, DMNB (Saint John)